New Lumigan: What a joke

Discussion in 'Allergan' started by Anonymous, Sep 2, 2010 at 6:30 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    What the hell is wrong with this company? One of my docs told me about the new LUmigan and asked why it was coming out when Xalatan was going generic. I was embarassed and told him it would be new "Lumigan Light" and he said it wasn't going to work and he wouldn't be switching patients and fighting managed care before Xalatan goes L.O.E in March. He promised to still use Combigan but told me he was disgusted by the line extension.

    What the hell is Allergan thinking? Are all of us glaucoma reps going to have jobs in March?
     
  2. Anonymous

    Anonymous Guest

    OP: Well e-ask that question, I am sure you are an Alcon person trying to dig for info. Lumigan 0.01 will rock, same efficacy, better AE than Travatan, 1st line indication. Lumigan will grow share due to xalatan LOE, Travatan has promoted itself as a me-too to Xalatan for years, while everyone knows Lumigan drops IOP better. Travatan will be in deep trouble. Lumigan 0.01 has done very well in the three markets that have had it before the U.S. It will be fun... by the way watch Novartis drain your R&D budget, and with your already weak R&D pipeline you will not be around in a few years. They did the same thing with Ciba Ophthalmics, years ago.
     
  3. Anonymous

    Anonymous Guest

    OKAY- what crap are you smoking to come up with that bit of marketing wizzardtry to get the "old" Lumigan a new life? It's the old trick like any other drug that has gone from a once a day to extended release to some combo drug just to keep the patent going...and why with Lumigan?? The OP hit it on the head- Docs are not going to buy it- (blah blah better IOP) when it does come to a drug that may or maynot work as you say compared to the competition- the cheap competition will win every time. Cost is everything. You can't tell a doc that EVERY patient will benefit from lumigan when they have had experience with Xalantan and it has kicked butt for some of his patients. Cost rules medicine now.......

    In regards to jobs- I don't think that Glaucoma drugs will be marketed by reps very much longer- it will be a dying segment of pharma sales......Xalatan will kill the industry-
     
  4. Anonymous

    Anonymous Guest

    yes what nitwits are board is! What with new Lumigan we finally have to admit our hyperemia rates to our doctors. We've told them it's not bad and manageable and now we have to admit it was a bad drug for nearly 10 years. Lord, can't wait to get the backlash from Alcon and Pfizer (for the leftover time they have)
     
  5. Anonymous

    Anonymous Guest

    i got busted. One of my glaucoma specialists said to me that I had minimized the hyperemia impact for years. He was joking but I could tell he was serious. Dont' think I will get buy in. What happens with X going generic?
     
  6. Anonymous

    Anonymous Guest

    funny how none of you are mentioning the doubling or quadrupling of the bak in new lumigan.
     
  7. Anonymous

    Anonymous Guest

    I mentioned this to a KOL and he said this was a collasal waste of time with generic latanaprost hitting the market next year. He said patients dictate with cost and only branded PG's would get a trivial piece of the market? Do you think this is true?
     
  8. Anonymous

    Anonymous Guest

    Can you hear that? It's the sound of the Eye Care sales force being crushed.
     
  9. Anonymous

    Anonymous Guest

    Is this product going to be called Lumigan Light. How do we tell our doctors now that the old product had hyperemia. Jesus H Christ
     
  10. Anonymous

    Anonymous Guest

    I don't want to sell Lumigan Light. It's sooooo embarassing coming out 2 years late right before X goes generic and Trav tried to improve their product adding the Z. Jesus Christ is right!
     
  11. Anonymous

    Anonymous Guest

    I agree. This is an embarassment to our glaucoma reps. It's a last ditch effort to get a few scripts before X goes generic. My Pfizer rep said he was looking for a job but wouldn't sell on the glaucoma side b/c there was no future in this side. He's looking for anti-infectives
     
  12. Anonymous

    Anonymous Guest

    this is a very dumb idea. why can't we ever come up with an innovative product? this company really embarasses me.
     
  13. Anonymous

    Anonymous Guest

    Love all the nervous fake posters here. I am sure they are all alcon losers. Well in both markets where our Lumigan 0.01 is approved we have rocked. Now your "Me-Too selling that you are like Xalatan will kill you. Lumigan is the most efficacious, don't even try to argue agaisnt that. Now we are eual in A.E. if not less than that stinging crap yu call Travatan Z, have you been watching your share go donw the last 8 weeks, now we have Lumigan 0.01!!!!! BY the way Novartis will run you into the ground like they did the Ciba opthalmics division, oh you don't remember Ciba had Oph Drugs, well that is what people will be saying about Alcon with in 3-5 years. They only want your Srugrical stuff. Have fun selling to Primay Care at Novartis :)
     
  14. Anonymous

    Anonymous Guest

    i coudn't disagree more. Who is the dipshit that thinks we will sell lots of ANY prostaglandin after Xalatan LOE. It's not TZ fool. We're fighting subsitution of monumental scale. X will be the first ophthalmic agent to go generic of billion dollar proportion. This last post sounds like someone that did not go to college or drinking the Kool Aid in marketing. Mark my words, it will be a bloodbath next Spring for us
     
  15. Anonymous

    Anonymous Guest

    why a nat'l sales meeting for this stupid product? this is getting embarassing for glaucoma reps!
     

Share This Page